What percent of IPHA is sold short?

35.8% of Innate Pharma (IPHA) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is IPHA a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for Innate Pharma (IPHA).

IPHA Short Volume Hit 35.8%

Also trades as: IPH.PA (PAR) · $vol 1M · IPHYF (OTC) · $vol 0M

$1.56

-0.03 (-1.89%)

Weekly Expected Move ±6.7%

$1 $1 $2 $2 $2

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $146.5M mcap · 71M float · 0.167% daily turnover · Short 30% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Short Volume Summary

2026-10-01

30.3%

Short Ratio

of total volume

43.3%

20-Day Avg

36.8%

50-Day Avg

▲ Rising

5-Day Trend

0.0M

Short Volume

0.0M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	6,508	29,216	22.3%
NYSE	3,375	3,381	99.8%
BATS	5	5	91.1%

IPHA Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet